Experts are excitedly investigating retatrutide, a innovative drug created by Eli Lilly, as a possible breakthrough in weight loss . Unlike many previous approaches, retatrutide is a dual -action agonist targeting both GLP-1 and GIP, substances that affect satiety and glucose regulation . Early